May 10-11, 2013
Course on the Diagnostic Histopathology of Soft Tissue Tumors
Treviso, Italy: The Department of Pathology of Treviso has organized a two-day course focused upon the diagnostic pathology and molecular genetics of soft tissue tumors. The course will be co-directed by Dr. Christopher Fletcher of Harvard Medical School. The course is directed to pathologists and will include lectures and slide seminars. Participants are kindly invited to submit one case for the slide seminar. The first 70 registrants will receive the slide box at the end of the course.
May 29-31, 2013
Meeting of the European MusuloSkeletal Oncology Society
4th Cancer Targets and Therapeutics
Las Vegas,, California: The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact.
February 27-March 2, 2013
Conference on State of the Art Molecular Imaging
San Diego, California: This first joint meeting between the AACR and the Society of Nuclear Medicine and Molecular Imaging will bring together imaging scientists with biologists in basic, translational, and clinical research to explore how new findings in molecular imaging can improve cancer diagnostics, treatment, and patient outcomes.
March 5, 2013 at 2:30pm
What's Next in Next-Generation Sequencing?
Free Webinar: The webinar to be conducted in March will track the evolution of next-generation sequencing (NGS) and what the future holds in terms of the technology and its applications. Following brief presentations given by our panel of experts, there will be a live Q&A session where attendees can ask questions and discuss NGS-related challenges they are facing in their laboratories.
February 6-8, 2012: Pediatric Cancer Translational Genomics
Scottsdale, Arizona: Join internationally recognized experts in the field of pediatric oncology for a collective conversation on how state-of-the-art genomics research may be applied to the translational oncology of pediatric solid tumors.
February 9-11, 2012: 18th Annual Network of Oncology Clinicians and Researchers (NOCR) Meeting
Las Vegas, Nevada: This annual update features clinical case and panel discussions, debates, and Meet the Expert sessions for exchanging the latest information on the diagnosis and management of solid tumors and hematologic malignancies. For 2012, we are expanding the agenda to include discussions on sarcoma and GIST, cutting-edge research in melanoma, and a special session on managing women’s issues in oncology.
February 29: Rare Disease Day Lobby Day
Join us for a Rare Disease Day Lobby Day in Washington DC to support ULTRA. The Unlocking Lifesaving Treatments for Rare diseases Act of 2012, or ULTRA, H.R. 3737, will improve access to the FDA's Accelerated Approval process for very rare diseases, provide a more predictable regulatory process, bring down development costs, and spur investment in the development of treatments. Additionally, ULTRA requires the FDA to use the best science available, ensuring treatments are safe and effective and reach patients sooner.
February 29 - March 2, 2012: British Sarcoma Group Conference
Oxford, United Kingdom
March 9-10: European Society for Medical Oncology Conference on Sarcoma and GIST
Milan, Italy: The 4th ESMO Conference on Sarcoma and GIST will provide a wide-ranging overview of current medical therapy of soft tissue sarcomas and GIST.
March 15-16: EORTC Group Annual Meeting
Brussels, Belgium: The EORTC Network comprises over 300 hospitals and cancer centers in over 30 countries which include some 2,500 collaborators from all disciplines involved in cancer treatment and research. The conference offers a unique opportunity to gather all the partners (including national research organizations, health authorities, patient advocacy groups, European Commission, cancer leagues, and the pharmaceutical industry) involved in the EORTC mission.
March 24 at 9:00am: "Meet the Sarcoma Experts" Forum
Boston, Massachusetts: This forum will be an educational experience for patients and their families at Massachusetts General Hospital. Topics covered include multidisciplinary treatment of sarcoma and advancements in sarcoma treatment. Please RSVP by March 19, 2012 to Donna Silva. Breakfast and refreshments will be served, and parking will be validated.
March 30 - April 1, 2012: The OMG! Cancer Summit
Las Vegas, California: An oncology conference and social networking event for the young adult cancer movement.
June 20, 2012: Online Sarcoma Support Group Meeting
Online: Memorial Sloan-Kettering Cancer Center will be hosting a live, online, confidential support group program for sarcoma patients on June 20th. This program is open to the public. Please feel free to make this information available to your community.
September 20-22, 2012
MusculoSkeletal Tumor Society (MSTS) Annual Meeting
in Tampa, Florida
September 29 - October 4
Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence
in Polonia Castle in Pultusk, Poland: The conference will bring together biologists and clinicians to implement the interdisciplinary approach that is needed to advance research and therapy of rare childhood sarcomas.
November 14-17, 2012
Connective Tissue Oncology Society (CTOS) Annual Meeting
in Prague, Czech Republic
December 19, 2012
Virtual Sarcoma Support Group
Online: This group will provide an opportunity for patients with sarcoma to talk to each other in a live, online, confidential forum. This group will be facilitated by Linda Mathew, LCSW.
January 10-12, 2011: EuroBoNeT and Conticanet Annual Meeting
Paris, France: This meeting will be organised by EuroBoNeT and Conticanet, both European funded network of Excellences in their last year of European funding. EuroBoNeT is a network focussing on bone tumours (both benign and malignant) and bone formation. Their interests are divided into 4 main subjects: cartilage forming tumours (i.e. osteochondroma, enchondroma, chondrosarcoma), bone forming tumours (osteosarcoma, but also chordomas, angiosarcomas), giant cell tumour and bone formation, and Ewing sarcomas. The research focuses on pathology, biology and genetics of these tumours, in order to better understand how these tumours arise and how we might be able to treat them. Besides research, teaching of clinicians and pathologist is also part of their mission. Recently this resulted in publications on treatment guidelines on bone sarcomas and soft tissue sarcomas. Conticanet is a similar network, but focusing on connective tissue cancers. Together with EuroBoNeT they also were involved in the soft tissue sarcoma treatment guidelines and produced a similar one of GISTs.
February 9-11: The British Sarcoma Group Conference
Gateshead, United Kingdom: Details to be announced.
February 14-16: Practical clinical, radiological and pathological diagnosis of skeletal tumours
Leiden, Netherlands: This course aims at the practical histopathological diagnosis of tumours of bones and joints. It is meant for (trainee) pathologists, orthopaedic surgeons, radiologists, clinical oncologists and paediatricians. The course focuses on the use of clinical and radiodiagnostic data and the pathological differential diagnosis.
February 23-25: 18th International Molecular Medicine Tri-Conference
San Francisco, CA
March 7-9: 9th International Symposium on Targeted Anticancer Therapies
March 9-13: NCCN 16th Annual Conference
Hollywood, Florida: An NCCN Sarcoma Guidelines Update will take place at this conference on March 12 at 9:20am.
March 24: Optimal role of patient organisations in drug development
De Rode Hoed, Amsterdam, The Netherlands: Conference about how partnership with patient organisations can contribute to more efficient drug development
April 16: Meet the Sarcoma Experts - Fifth Annual Forum
Boston, Massachusetts: Fourteen sarcoma experts provide information about sarcoma and its treatment. RSVP by April 8th!
May 4-6: The 35th Meeting of the Scandinavian Sarcoma Group
Malmö Börshus, Malmö, Sweden
May 5: GIST Educational Meeting
Boston, Massachusetts: The GIST Cancer Research Fund is holding a special occasion of discovery and discussion highlighting new GIST research at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute on Thursday, May 5th: 9:30-1:00PM (lunch provided). Please RSVP by Wednesday, April 27, to Christina Novak at 617. 424.4193. Space is limited. Speakers will be: James E. Butrynski, MD; George D. Demerti, MD; Janathan A. Fletcher, MD; Judy E. Garber, MD, MPH; Suzanne George, MD; Katherine A. Janeway, MD; Adrian Marino-Enriquez, MD; Amy S. Pilotte, NP; Kathleen M. Polson, NP; and Chandrajit P. Raut, MD.
September 14-18: Frontiers in Basic Cancer Research
San Francisco, California: This prestigious conference will be the second of its kind focused on the latest advances in basic cancer research. It is a broad-based meeting with the goals of presenting the best in basic cancer research and giving early-career investigators a unique opportunity to interact with luminaries in the field. The goal of the conference is to create a synergy between many subfields of basic cancer research that will encourage and strengthen collaborative efforts.
September 15-18: 16th International Symposium on Limb Salvage
September 23-27: The European Multidisciplinary Cancer Congress
Stockholm, Sweden: The biannual European Multidisciplinary Cancer Congresses have recently undergone a re-brand. Much more than a re-name and new tagline 'Integrating basic & translational science, surgery, radiotherapy, medical oncology & care,' the previous Congress has consequently been re-branded to visually encompass the 16th ECCO, the 36th ESMO and the 30th ESTRO Congresses as well as the essential contribution of all ECCO’s other Founding Members in partnership - ESSO, EACR, EONS and SIOPE.
October 15-16: Australian Sarcoma Group 2011 Annual Sarcoma Conference
October 27-29: Combined MSTS/CTOS Meeting
Chicago, IL: Sheraton Chicago Hotel and Towers
October 27 at 8am: 2011 SARC Meeting at CTOS
Chicago, IL: Sheraton Chicago Hotel and Towers
November 12-16: Molecular Targets and Cancer Therapeutics
San Francisco, California: This major conference brings together over 3,000 academics, scientists, and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.
November 17-19: 2nd SPAEN Annual Conference
Berlin, Germany: This will be the 2nd SPAEN Annual Conference for Organizations Representing Patients with Sarcomas, GIST or Desmoid Tumours. The conference aims to provide Sarcoma, GIST and Desmoid patient advocates with an opportunity to share experience and best practice, as well as to learn about advances and challenges in the treatment of rare cancers. The three day conference will focus on research, treatment and advocacy/capacity building. Leading European Sarcoma Experts will join us to present the latest news and answer your questions.
November 23-24: European Cancer Control Summit on the Role of Cancer Registries
Brussels, Belgium: Cancer registry funding organisations, epidemiological and clinical researchers, programme owners and managers will join policy-makers and patient advocates to discuss the value of high-quality information on cancer in Europe, particularly in terms of the development, analysis, optimal use and exchange of European cancer registry data at this high-level meeting.
December 15: CancerCare's Treatment Update on Soft Tissue Sarcoma
A free workshop for people living with soft tissue sarcoma, their families, friends and health care professionals. Pre-registration is required. Registered participants can join the call via a toll-free number and online streaming. Learn more by viewing the brochure.